Vasculitis

Clinical trials

Rituximab and rheumatology practice in the COVID-19 era

How can rheumatologists respond to the challenges associated with rituximab use during the pandemic?

Browse the hub

Anifrolumab for the treatment of lupus

Perspective on the approval of anifrolumab and the importance of endpoints in lupus trials.

Visit the hub

New additions to the Adis Journal Club

A monthly selection of topical peer-reviewed articles from the Adis journals, curated by the editors.

Visit the hub

JAK inhibitor safety

Data summary, expert discussion, & research news on the potential risks associated with JAK inhibitors.

ACR Convergence 2021 highlights

3–9 November: Keep up with the latest news and interviews from the conference.

Visit the conference hub

Febuxostat and cardiovascular risk in people with gout

How will the FAST trial results impact regulatory guidance & clinical practice?

Read the article

Telemedicine in rheumatology

Experts discuss the increasing use of telemedicine in rheumatology during the COVID-19 pandemic.

Browse the hub

Get ready for ACR Convergence 2020

5 – 9 November: Preview the conference with session recommendations and updates on upcoming coverage.

Visit the conference hub

02-05-2018 | Granulomatosis with polyangiitis | Article

Rituximab for induction and maintenance therapy of granulomatosis with polyangiitis: A single-centre cohort study on 114 patients

Puéchal X et al. Rheumatology (Oxford) 2018: key117. doi: 10.1093/rheumatology/key117

25-04-2018 | ANCA-associated vasculitis | Article

Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: Results of a multicenter, randomized controlled, phase III trial (MAINRITSAN2)

Charles P et al. Ann Rheum Dis 2018; Advance online publication. doi: 10.1136/annrheumdis-2017-212878

15-05-2017 | Vasculitis | Article

The value of ultrasound in diagnosing extracranial large-vessel vasculitis compared to FDG-PET/CT: A retrospective study

In this study, the authors found Doppler sonography to be a potent method in diagnosing extracranial large-vessel vasculitis, detecting 4 out of 5 cases in the study cohort.

Löffler C, Hoffend J, Benck U, Krämer BK, Bergner R. Clin Rheumatol 2017;36:2079–2086. doi:10.1007/s10067-017-3669-7

12-04-2017 | Quality of life | Article

Quality of life of patients treated for giant cell arteritis: a case-control study

Jobard et al postulated that giant cell arteritis (GCA) patients taking high dose corticosteroids had no significant impairment of quality of life (QOL) compared with controls in their study. GCA complications did not seem to have any major impact on QOL.

Clin Rheumatol 2017; advance online publication; doi:10.1007/s10067-017-3619-4

22-01-2017 | Vasculitis | Article

Efficacy and safety of long-term treatment with low-dose rituximab for relapsing mixed cryoglobulinemia vasculitis

The results of this study suggest that use of low-dose rituximab for repeated treatment of relapsing mixed cryoglobulinemia vasculitis is safe, efficacious, and cost-effective for long-term management.

Colantuono S et al. Clin Rheumatol 2017;36:617–623. doi:10.1007/s10067-017-3552-6

More on vasculitis

Image Credits

Springer Medicine, IV drip/© © Trsakaoe / stock.adobe.com, Anifrolumab for the treatment of lupus/© ustas / stock.adobe.com, Adis Journal Club, Magnifying glass and laptop/© Michail_Petrov-96 / Getty Images / iStock, ACR 2021_teaser image/© rocketclips/ stock.adobe.com; dragana991 / Getty Images / iStock, Febuxostat and CV risk signpost image/© hriana / stock.adobe.com, Telemedicine_allFloorbox, ACR 2020_teaser image/© Gennady Danilkin / stock.adobe.com, The value of ultrasound in diagnosing extracranial large-vessel vasculitis compared to FDG-PET/CT: A retrospective study/© International League of Associations for Rheumatology (ILAR) 2017, Pills in elderly woman's hand (symbolic image with model)